Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma–type morphology after heart transplant

Bashar M. Bata, Jose S Pulido, Sanjay V. Patel, Shakila P. Khan, Diva Salomao, Thomas G. Boyce, Erick D. Bothun

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Post-transplant lymphoproliferative disorder (PTLD) has rarely been associated with ocular manifestations. We report a case of bilateral ocular involvement by PTLD with histopathologic features of extranodal marginal zone (MALT) lymphoma in an 8-year-old boy following orthotopic heart transplantation. The anterior segment disease was treated successfully using a combination of intraocular and systemic injections of humanized anti-CD20 antibody (rituximab).

Original languageEnglish (US)
Pages (from-to)159-161
Number of pages3
JournalJournal of AAPOS
Volume22
Issue number2
DOIs
StatePublished - Apr 1 2018

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Ophthalmology

Fingerprint Dive into the research topics of 'Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma–type morphology after heart transplant'. Together they form a unique fingerprint.

Cite this